Global and China Neutropenia Drugs Market Insights, Forecast to 2026

SKU ID : QYR-16037013 | Publishing Date : 06-Aug-2020 | No. of pages : 129

Detailed TOC of Global and China Neutropenia Drugs Market Insights, Forecast to 2026

1 Study Coverage
    1.1 Neutropenia Drugs Product Introduction
    1.2 Market Segments
    1.3 Key Neutropenia Drugs Manufacturers Covered: Ranking by Revenue
    1.4 Market by Type
        1.4.1 Global Neutropenia Drugs Market Size Growth Rate by Type
        1.4.2 Capsule
        1.4.3 Injection
    1.5 Market by Application
        1.5.1 Global Neutropenia Drugs Market Size Growth Rate by Application
        1.5.2 Hospital
        1.5.3 Clinic
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Neutropenia Drugs Market Size, Estimates and Forecasts
        2.1.1 Global Neutropenia Drugs Revenue 2015-2026
        2.1.2 Global Neutropenia Drugs Sales 2015-2026
    2.2 Global Neutropenia Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    2.3 Neutropenia Drugs Historical Market Size by Region (2015-2020)
        2.3.1 Global Neutropenia Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
        2.3.2 Global Neutropenia Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
    2.4 Neutropenia Drugs Market Estimates and Projections by Region (2021-2026)
        2.4.1 Global Neutropenia Drugs Sales Forecast by Region (2021-2026)
        2.4.2 Global Neutropenia Drugs Revenue Forecast by Region (2021-2026)

3 Global Neutropenia Drugs Competitor Landscape by Players
    3.1 Global Top Neutropenia Drugs Sales by Manufacturers
        3.1.1 Global Neutropenia Drugs Sales by Manufacturers (2015-2020)
        3.1.2 Global Neutropenia Drugs Sales Market Share by Manufacturers (2015-2020)
    3.2 Global Neutropenia Drugs Manufacturers by Revenue
        3.2.1 Global Neutropenia Drugs Revenue by Manufacturers (2015-2020)
        3.2.2 Global Neutropenia Drugs Revenue Share by Manufacturers (2015-2020)
        3.2.3 Global Neutropenia Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
        3.2.4 Global Top 10 and Top 5 Companies by Neutropenia Drugs Revenue in 2019
        3.2.5 Global Neutropenia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Neutropenia Drugs Price by Manufacturers
    3.4 Global Neutropenia Drugs Manufacturing Base Distribution, Product Types
        3.4.1 Neutropenia Drugs Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Neutropenia Drugs Product Type
        3.4.3 Date of International Manufacturers Enter into Neutropenia Drugs Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
    4.1 Global Neutropenia Drugs Market Size by Type (2015-2020)
        4.1.1 Global Neutropenia Drugs Sales by Type (2015-2020)
        4.1.2 Global Neutropenia Drugs Revenue by Type (2015-2020)
        4.1.3 Neutropenia Drugs Average Selling Price (ASP) by Type (2015-2026)
    4.2 Global Neutropenia Drugs Market Size Forecast by Type (2021-2026)
        4.2.1 Global Neutropenia Drugs Sales Forecast by Type (2021-2026)
        4.2.2 Global Neutropenia Drugs Revenue Forecast by Type (2021-2026)
        4.2.3 Neutropenia Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
    4.3 Global Neutropenia Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
    5.1 Global Neutropenia Drugs Market Size by Application (2015-2020)
        5.1.1 Global Neutropenia Drugs Sales by Application (2015-2020)
        5.1.2 Global Neutropenia Drugs Revenue by Application (2015-2020)
        5.1.3 Neutropenia Drugs Price by Application (2015-2020)
    5.2 Neutropenia Drugs Market Size Forecast by Application (2021-2026)
        5.2.1 Global Neutropenia Drugs Sales Forecast by Application (2021-2026)
        5.2.2 Global Neutropenia Drugs Revenue Forecast by Application (2021-2026)
        5.2.3 Global Neutropenia Drugs Price Forecast by Application (2021-2026)

6 China by Players, Type and Application
    6.1 China Neutropenia Drugs Market Size YoY Growth 2015-2026
        6.1.1 China Neutropenia Drugs Sales YoY Growth 2015-2026
        6.1.2 China Neutropenia Drugs Revenue YoY Growth 2015-2026
        6.1.3 China Neutropenia Drugs Market Share in Global Market 2015-2026
    6.2 China Neutropenia Drugs Market Size by Players (International and Local Players)
        6.2.1 China Top Neutropenia Drugs Players by Sales (2015-2020)
        6.2.2 China Top Neutropenia Drugs Players by Revenue (2015-2020)
    6.3 China Neutropenia Drugs Historic Market Review by Type (2015-2020)
        6.3.1 China Neutropenia Drugs Sales Market Share by Type (2015-2020)
        6.3.2 China Neutropenia Drugs Revenue Market Share by Type (2015-2020)
        6.3.3 China Neutropenia Drugs Price by Type (2015-2020)
    6.4 China Neutropenia Drugs Market Estimates and Forecasts by Type (2021-2026)
        6.4.1 China Neutropenia Drugs Sales Forecast by Type (2021-2026)
        6.4.2 China Neutropenia Drugs Revenue Forecast by Type (2021-2026)
        6.4.3 China Neutropenia Drugs Price Forecast by Type (2021-2026)
    6.5 China Neutropenia Drugs Historic Market Review by Application (2015-2020)
        6.5.1 China Neutropenia Drugs Sales Market Share by Application (2015-2020)
        6.5.2 China Neutropenia Drugs Revenue Market Share by Application (2015-2020)
        6.5.3 China Neutropenia Drugs Price by Application (2015-2020)
    6.6 China Neutropenia Drugs Market Estimates and Forecasts by Application (2021-2026)
        6.6.1 China Neutropenia Drugs Sales Forecast by Application (2021-2026)
        6.6.2 China Neutropenia Drugs Revenue Forecast by Application (2021-2026)
        6.6.3 China Neutropenia Drugs Price Forecast by Application (2021-2026)

7 North America
    7.1 North America Neutropenia Drugs Market Size YoY Growth 2015-2026
    7.2 North America Neutropenia Drugs Market Facts & Figures by Country
        7.2.1 North America Neutropenia Drugs Sales by Country (2015-2020)
        7.2.2 North America Neutropenia Drugs Revenue by Country (2015-2020)
        7.2.3 U.S.
        7.2.4 Canada

8 Europe
    8.1 Europe Neutropenia Drugs Market Size YoY Growth 2015-2026
    8.2 Europe Neutropenia Drugs Market Facts & Figures by Country
        8.2.1 Europe Neutropenia Drugs Sales by Country
        8.2.2 Europe Neutropenia Drugs Revenue by Country
        8.2.3 Germany
        8.2.4 France
        8.2.5 U.K.
        8.2.6 Italy
        8.2.7 Russia

9 Asia Pacific
    9.1 Asia Pacific Neutropenia Drugs Market Size YoY Growth 2015-2026
    9.2 Asia Pacific Neutropenia Drugs Market Facts & Figures by Country
        9.2.1 Asia Pacific Neutropenia Drugs Sales by Region (2015-2020)
        9.2.2 Asia Pacific Neutropenia Drugs Revenue by Region
        9.2.3 China
        9.2.4 Japan
        9.2.5 South Korea
        9.2.6 India
        9.2.7 Australia
        9.2.8 Taiwan
        9.2.9 Indonesia
        9.2.10 Thailand
        9.2.11 Malaysia
        9.2.12 Philippines
        9.2.13 Vietnam

10 Latin America
    10.1 Latin America Neutropenia Drugs Market Size YoY Growth 2015-2026
    10.2 Latin America Neutropenia Drugs Market Facts & Figures by Country
        10.2.1 Latin America Neutropenia Drugs Sales by Country
        10.2.2 Latin America Neutropenia Drugs Revenue by Country
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Neutropenia Drugs Market Size YoY Growth 2015-2026
    11.2 Middle East and Africa Neutropenia Drugs Market Facts & Figures by Country
        11.2.1 Middle East and Africa Neutropenia Drugs Sales by Country
        11.2.2 Middle East and Africa Neutropenia Drugs Revenue by Country
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 U.A.E

12 Company Profiles
    12.1 Apotex Inc.
        12.1.1 Apotex Inc. Corporation Information
        12.1.2 Apotex Inc. Description and Business Overview
        12.1.3 Apotex Inc. Sales, Revenue and Gross Margin (2015-2020)
        12.1.4 Apotex Inc. Neutropenia Drugs Products Offered
        12.1.5 Apotex Inc. Recent Development
    12.2 Biogenomics Limited
        12.2.1 Biogenomics Limited Corporation Information
        12.2.2 Biogenomics Limited Description and Business Overview
        12.2.3 Biogenomics Limited Sales, Revenue and Gross Margin (2015-2020)
        12.2.4 Biogenomics Limited Neutropenia Drugs Products Offered
        12.2.5 Biogenomics Limited Recent Development
    12.3 Cellerant Therapeutics, Inc.
        12.3.1 Cellerant Therapeutics, Inc. Corporation Information
        12.3.2 Cellerant Therapeutics, Inc. Description and Business Overview
        12.3.3 Cellerant Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
        12.3.4 Cellerant Therapeutics, Inc. Neutropenia Drugs Products Offered
        12.3.5 Cellerant Therapeutics, Inc. Recent Development
    12.4 Coherus BioSciences, Inc.
        12.4.1 Coherus BioSciences, Inc. Corporation Information
        12.4.2 Coherus BioSciences, Inc. Description and Business Overview
        12.4.3 Coherus BioSciences, Inc. Sales, Revenue and Gross Margin (2015-2020)
        12.4.4 Coherus BioSciences, Inc. Neutropenia Drugs Products Offered
        12.4.5 Coherus BioSciences, Inc. Recent Development
    12.5 Dr. Reddy’s Laboratories Limited
        12.5.1 Dr. Reddy’s Laboratories Limited Corporation Information
        12.5.2 Dr. Reddy’s Laboratories Limited Description and Business Overview
        12.5.3 Dr. Reddy’s Laboratories Limited Sales, Revenue and Gross Margin (2015-2020)
        12.5.4 Dr. Reddy’s Laboratories Limited Neutropenia Drugs Products Offered
        12.5.5 Dr. Reddy’s Laboratories Limited Recent Development
    12.6 Ligand Pharmaceuticals, Inc.
        12.6.1 Ligand Pharmaceuticals, Inc. Corporation Information
        12.6.2 Ligand Pharmaceuticals, Inc. Description and Business Overview
        12.6.3 Ligand Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
        12.6.4 Ligand Pharmaceuticals, Inc. Neutropenia Drugs Products Offered
        12.6.5 Ligand Pharmaceuticals, Inc. Recent Development
    12.7 NAL Pharmaceuticals Ltd.
        12.7.1 NAL Pharmaceuticals Ltd. Corporation Information
        12.7.2 NAL Pharmaceuticals Ltd. Description and Business Overview
        12.7.3 NAL Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
        12.7.4 NAL Pharmaceuticals Ltd. Neutropenia Drugs Products Offered
        12.7.5 NAL Pharmaceuticals Ltd. Recent Development
    12.8 Prolong Pharmaceuticals, LLC
        12.8.1 Prolong Pharmaceuticals, LLC Corporation Information
        12.8.2 Prolong Pharmaceuticals, LLC Description and Business Overview
        12.8.3 Prolong Pharmaceuticals, LLC Sales, Revenue and Gross Margin (2015-2020)
        12.8.4 Prolong Pharmaceuticals, LLC Neutropenia Drugs Products Offered
        12.8.5 Prolong Pharmaceuticals, LLC Recent Development
    12.9 Richter Gedeon Nyrt.
        12.9.1 Richter Gedeon Nyrt. Corporation Information
        12.9.2 Richter Gedeon Nyrt. Description and Business Overview
        12.9.3 Richter Gedeon Nyrt. Sales, Revenue and Gross Margin (2015-2020)
        12.9.4 Richter Gedeon Nyrt. Neutropenia Drugs Products Offered
        12.9.5 Richter Gedeon Nyrt. Recent Development
    12.10 Sandoz International GmbH
        12.10.1 Sandoz International GmbH Corporation Information
        12.10.2 Sandoz International GmbH Description and Business Overview
        12.10.3 Sandoz International GmbH Sales, Revenue and Gross Margin (2015-2020)
        12.10.4 Sandoz International GmbH Neutropenia Drugs Products Offered
        12.10.5 Sandoz International GmbH Recent Development
    12.11 Apotex Inc.
        12.11.1 Apotex Inc. Corporation Information
        12.11.2 Apotex Inc. Description and Business Overview
        12.11.3 Apotex Inc. Sales, Revenue and Gross Margin (2015-2020)
        12.11.4 Apotex Inc. Neutropenia Drugs Products Offered
        12.11.5 Apotex Inc. Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Porter’s Five Forces Analysis
    13.5 Primary Interviews with Key Neutropenia Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Neutropenia Drugs Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Figures, Tables and Charts Available in Global and China Neutropenia Drugs Market Insights, Forecast to 2026

List of Tables
    Table 1. Neutropenia Drugs Market Segments
    Table 2. Ranking of Global Top Neutropenia Drugs Manufacturers by Revenue (US$ Million) in 2019
    Table 3. Global Neutropenia Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
    Table 4. Major Manufacturers of Capsule
    Table 5. Major Manufacturers of Injection
    Table 6. Global Neutropenia Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
    Table 7. Global Neutropenia Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
    Table 8. Global Neutropenia Drugs Sales by Regions 2015-2020 (K MT)
    Table 9. Global Neutropenia Drugs Sales Market Share by Regions (2015-2020)
    Table 10. Global Neutropenia Drugs Revenue by Regions 2015-2020 (US$ Million)
    Table 11. Global Neutropenia Drugs Sales Forecast by Region (2021-2026) (K MT)
    Table 12. Global Neutropenia Drugs Sales by Manufacturers (2015-2020) (K MT)
    Table 13. Global Neutropenia Drugs Sales Share by Manufacturers (2015-2020)
    Table 14. Global Neutropenia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
    Table 15. Global Neutropenia Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neutropenia Drugs as of 2019)
    Table 16. Neutropenia Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
    Table 17. Neutropenia Drugs Revenue Share by Manufacturers (2015-2020)
    Table 18. Key Manufacturers Neutropenia Drugs Price (2015-2020) (USD/MT)
    Table 19. Neutropenia Drugs Manufacturers Manufacturing Base Distribution and Headquarters
    Table 20. Manufacturers Neutropenia Drugs Product Type
    Table 21. Date of International Manufacturers Enter into Neutropenia Drugs Market
    Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 23. Global Neutropenia Drugs Sales by Type (2015-2020) (K MT)
    Table 24. Global Neutropenia Drugs Sales Share by Type (2015-2020)
    Table 25. Global Neutropenia Drugs Revenue by Type (2015-2020) (US$ Million)
    Table 26. Global Neutropenia Drugs Revenue Share by Type (2015-2020)
    Table 27. Neutropenia Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
    Table 28. Global Neutropenia Drugs Sales Share by Type (2021-2026)
    Table 29. Global Neutropenia Drugs Sales by Application (2015-2020) (K MT)
    Table 30. Global Neutropenia Drugs Sales Share by Application (2015-2020)
    Table 31. Global Neutropenia Drugs Sales Share by Application (2021-2026)
    Table 32. Global Neutropenia Drugs Sales Market Share Forecast by Application (2021-2026)
    Table 33. Global Neutropenia Drugs Revenue by Application (2015-2020) (US$ Million)
    Table 34. Global Neutropenia Drugs Revenue Market Share Forecast by Application (2021-2026)
    Table 35. China Neutropenia Drugs Sales (K MT) of Key Companies (2015-2020)
    Table 36. China Neutropenia Drugs Sales Share by Company (2015-2020)
    Table 37. China Neutropenia Drugs Revenue (US$ Million) by Company (2015-2020)
    Table 38. China Neutropenia Drugs Sales (K MT) by Type (2015-2020)
    Table 39. China Neutropenia Drugs Sales Share by Type (2015-2020)
    Table 40. China Neutropenia Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
    Table 41. China Neutropenia Drugs Price (K MT) by Type (2015-2020)
    Table 42. China Neutropenia Drugs Sales (K MT) by Type (2021-2026)
    Table 43. China Neutropenia Drugs Sales Share by Type (2021-2026)
    Table 44. China Neutropenia Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
    Table 45. China Neutropenia Drugs Revenue Share by Type (2021-2026)
    Table 46. China Neutropenia Drugs Price (K MT) by Type (2021-2026)
    Table 47. China Neutropenia Drugs Sales (K MT) by Application (2015-2020)
    Table 48. China Neutropenia Drugs Sales Share by Application (2015-2020)
    Table 49. China Neutropenia Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
    Table 50. China Neutropenia Drugs Sales (K MT) by Application (2021-2026)
    Table 51. China Neutropenia Drugs Sales Share by Application (2021-2026)
    Table 52. China Neutropenia Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
    Table 53. China Neutropenia Drugs Revenue Share by Application (2021-2026)
    Table 54. North America Neutropenia Drugs Sales by Country (2015-2020) (K MT)
    Table 55. North America Neutropenia Drugs Sales Market Share by Country (2015-2020)
    Table 56. North America Neutropenia Drugs Revenue by Country (2015-2020) (US$ Million)
    Table 57. North America Neutropenia Drugs Revenue Market Share by Country (2015-2020)
    Table 58. Europe Neutropenia Drugs Sales by Country (2015-2020) (K MT)
    Table 59. Europe Neutropenia Drugs Sales Market Share by Country (2015-2020)
    Table 60. Europe Neutropenia Drugs Revenue by Country (2015-2020) (US$ Million)
    Table 61. Europe Neutropenia Drugs Revenue Market Share by Country (2015-2020)
    Table 62. Asia Pacific Neutropenia Drugs Sales by Region (2015-2020) (K MT)
    Table 63. Asia Pacific Neutropenia Drugs Sales Market Share by Region (2015-2020)
    Table 64. Asia Pacific Neutropenia Drugs Revenue by Region (2015-2020) (US$ Million)
    Table 65. Asia Pacific Neutropenia Drugs Revenue Market Share by Region (2015-2020)
    Table 66. Latin America Neutropenia Drugs Sales by Country (2015-2020) (K MT)
    Table 67. Latin America Neutropenia Drugs Sales Market Share by Country (2015-2020)
    Table 68. Latin Americaa Neutropenia Drugs Revenue by Country (2015-2020) (US$ Million)
    Table 69. Latin America Neutropenia Drugs Revenue Market Share by Country (2015-2020)
    Table 70. Middle East and Africa Neutropenia Drugs Sales by Country (2015-2020) (K MT)
    Table 71. Middle East and Africa Neutropenia Drugs Sales Market Share by Country (2015-2020)
    Table 72. Middle East and Africa Neutropenia Drugs Revenue by Country (2015-2020) (US$ Million)
    Table 73. Middle East and Africa Neutropenia Drugs Revenue Market Share by Country (2015-2020)
    Table 74. Apotex Inc. Corporation Information
    Table 75. Apotex Inc. Description and Business Overview
    Table 76. Apotex Inc. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 77. Apotex Inc. Neutropenia Drugs Product
    Table 78. Apotex Inc. Recent Development
    Table 79. Biogenomics Limited Corporation Information
    Table 80. Biogenomics Limited Description and Business Overview
    Table 81. Biogenomics Limited Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 82. Biogenomics Limited Product
    Table 83. Biogenomics Limited Recent Development
    Table 84. Cellerant Therapeutics, Inc. Corporation Information
    Table 85. Cellerant Therapeutics, Inc. Description and Business Overview
    Table 86. Cellerant Therapeutics, Inc. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 87. Cellerant Therapeutics, Inc. Product
    Table 88. Cellerant Therapeutics, Inc. Recent Development
    Table 89. Coherus BioSciences, Inc. Corporation Information
    Table 90. Coherus BioSciences, Inc. Description and Business Overview
    Table 91. Coherus BioSciences, Inc. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 92. Coherus BioSciences, Inc. Product
    Table 93. Coherus BioSciences, Inc. Recent Development
    Table 94. Dr. Reddy’s Laboratories Limited Corporation Information
    Table 95. Dr. Reddy’s Laboratories Limited Description and Business Overview
    Table 96. Dr. Reddy’s Laboratories Limited Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 97. Dr. Reddy’s Laboratories Limited Product
    Table 98. Dr. Reddy’s Laboratories Limited Recent Development
    Table 99. Ligand Pharmaceuticals, Inc. Corporation Information
    Table 100. Ligand Pharmaceuticals, Inc. Description and Business Overview
    Table 101. Ligand Pharmaceuticals, Inc. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 102. Ligand Pharmaceuticals, Inc. Product
    Table 103. Ligand Pharmaceuticals, Inc. Recent Development
    Table 104. NAL Pharmaceuticals Ltd. Corporation Information
    Table 105. NAL Pharmaceuticals Ltd. Description and Business Overview
    Table 106. NAL Pharmaceuticals Ltd. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 107. NAL Pharmaceuticals Ltd. Product
    Table 108. NAL Pharmaceuticals Ltd. Recent Development
    Table 109. Prolong Pharmaceuticals, LLC Corporation Information
    Table 110. Prolong Pharmaceuticals, LLC Description and Business Overview
    Table 111. Prolong Pharmaceuticals, LLC Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 112. Prolong Pharmaceuticals, LLC Product
    Table 113. Prolong Pharmaceuticals, LLC Recent Development
    Table 114. Richter Gedeon Nyrt. Corporation Information
    Table 115. Richter Gedeon Nyrt. Description and Business Overview
    Table 116. Richter Gedeon Nyrt. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 117. Richter Gedeon Nyrt. Product
    Table 118. Richter Gedeon Nyrt. Recent Development
    Table 119. Sandoz International GmbH Corporation Information
    Table 120. Sandoz International GmbH Description and Business Overview
    Table 121. Sandoz International GmbH Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 122. Sandoz International GmbH Product
    Table 123. Sandoz International GmbH Recent Development
    Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
    Table 125. Key Challenges
    Table 126. Market Risks
    Table 127. Main Points Interviewed from Key Neutropenia Drugs Players
    Table 128. Neutropenia Drugs Customers List
    Table 129. Neutropenia Drugs Distributors List
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Neutropenia Drugs Product Picture
    Figure 2. Global Neutropenia Drugs Sales Market Share by Type in 2020 & 2026
    Figure 3. Capsule Product Picture
    Figure 4. Injection Product Picture
    Figure 5. Global Neutropenia Drugs Sales Market Share by Application in 2020 & 2026
    Figure 6. Hospital
    Figure 7. Clinic
    Figure 8. Neutropenia Drugs Report Years Considered
    Figure 9. Global Neutropenia Drugs Market Size 2015-2026 (US$ Million)
    Figure 10. Global Neutropenia Drugs Sales 2015-2026 (K MT)
    Figure 11. Global Neutropenia Drugs Market Size Market Share by Region: 2020 Versus 2026
    Figure 12. Global Neutropenia Drugs Sales Market Share by Region (2015-2020)
    Figure 13. Global Neutropenia Drugs Sales Market Share by Region in 2019
    Figure 14. Global Neutropenia Drugs Revenue Market Share by Region (2015-2020)
    Figure 15. Global Neutropenia Drugs Revenue Market Share by Region in 2019
    Figure 16. Global Neutropenia Drugs Sales Share by Manufacturer in 2019
    Figure 17. The Top 10 and 5 Players Market Share by Neutropenia Drugs Revenue in 2019
    Figure 18. Neutropenia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
    Figure 19. Global Neutropenia Drugs Sales Market Share by Type (2015-2020)
    Figure 20. Global Neutropenia Drugs Sales Market Share by Type in 2019
    Figure 21. Global Neutropenia Drugs Revenue Market Share by Type (2015-2020)
    Figure 22. Global Neutropenia Drugs Revenue Market Share by Type in 2019
    Figure 23. Global Neutropenia Drugs Market Share by Price Range (2015-2020)
    Figure 24. Global Neutropenia Drugs Sales Market Share by Application (2015-2020)
    Figure 25. Global Neutropenia Drugs Sales Market Share by Application in 2019
    Figure 26. Global Neutropenia Drugs Revenue Market Share by Application (2015-2020)
    Figure 27. Global Neutropenia Drugs Revenue Market Share by Application in 2019
    Figure 28. China Neutropenia Drugs Sales Growth Rate 2015-2026 (K MT)
    Figure 29. China Neutropenia Drugs Revenue Growth Rate 2015-2026 (US$ Million)
    Figure 30. China Neutropenia Drugs Market Share in Global Market 2015-2026
    Figure 31. China 5 and 10 Largest Neutropenia Drugs Players Market Share by Revenue in Neutropenia Drugs in 2019
    Figure 32. China Neutropenia Drugs Revenue Share by Type (2015-2020)
    Figure 33. China Neutropenia Drugs Revenue Growth Rate by Type in 2015 & 2019
    Figure 34. China Neutropenia Drugs Revenue Share by Application (2015-2020)
    Figure 35. China Neutropenia Drugs Revenue Growth Rate by Application in 2015 & 2019
    Figure 36. North America Neutropenia Drugs Sales Growth Rate 2015-2020 (K MT)
    Figure 37. North America Neutropenia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 38. North America Neutropenia Drugs Sales Market Share by Country in 2019
    Figure 39. North America Neutropenia Drugs Revenue Market Share by Country in 2019
    Figure 40. U.S. Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 41. U.S. Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 42. Canada Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 43. Canada Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 44. Europe Neutropenia Drugs Sales Growth Rate 2015-2020 (K MT)
    Figure 45. Europe Neutropenia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 46. Europe Neutropenia Drugs Sales Market Share by Country in 2019
    Figure 47. Europe Neutropenia Drugs Revenue Market Share by Country in 2019
    Figure 48. Germany Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 49. Germany Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 50. France Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 51. France Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 52. U.K. Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 53. U.K. Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 54. Italy Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 55. Italy Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 56. Russia Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 57. Russia Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 58. Asia Pacific Neutropenia Drugs Sales Growth Rate 2015-2020 (K MT)
    Figure 59. Asia Pacific Neutropenia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 60. Asia Pacific Neutropenia Drugs Sales Market Share by Region in 2019
    Figure 61. Asia Pacific Neutropenia Drugs Revenue Market Share by Region in 2019
    Figure 62. China Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 63. China Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 64. Japan Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 65. Japan Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 66. South Korea Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 67. South Korea Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 68. India Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 69. India Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 70. Australia Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 71. Australia Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 72. Taiwan Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 73. Taiwan Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 74. Indonesia Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 75. Indonesia Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 76. Thailand Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 77. Thailand Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 78. Malaysia Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 79. Malaysia Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 80. Philippines Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 81. Philippines Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 82. Vietnam Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 83. Vietnam Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 84. Latin America Neutropenia Drugs Sales Growth Rate 2015-2020 (K MT)
    Figure 85. Latin America Neutropenia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 86. Latin America Neutropenia Drugs Sales Market Share by Country in 2019
    Figure 87. Latin America Neutropenia Drugs Revenue Market Share by Country in 2019
    Figure 88. Mexico Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 89. Mexico Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 90. Brazil Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 91. Brazil Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 92. Argentina Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 93. Argentina Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 94. Middle East and Africa Neutropenia Drugs Sales Growth Rate 2015-2020 (K MT)
    Figure 95. Middle East and Africa Neutropenia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 96. Middle East and Africa Neutropenia Drugs Sales Market Share by Country in 2019
    Figure 97. Middle East and Africa Neutropenia Drugs Revenue Market Share by Country in 2019
    Figure 98. Turkey Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 99. Turkey Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 100. Saudi Arabia Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 101. Saudi Arabia Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 102. U.A.E Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
    Figure 103. U.A.E Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 104. Porter's Five Forces Analysis
    Figure 105. Neutropenia Drugs Value Chain
    Figure 106. Channels of Distribution
    Figure 107. Distributors Profiles
    Figure 108. Bottom-up and Top-down Approaches for This Report
    Figure 109. Data Triangulation
    Figure 110. Key Executives Interviewed

Keyplayers in Global and China Neutropenia Drugs Market Insights, Forecast to 2026

Apotex Inc.
Biogenomics Limited
Cellerant Therapeutics, Inc.
Coherus BioSciences, Inc.
Dr. Reddy’s Laboratories Limited
Ligand Pharmaceuticals, Inc.
NAL Pharmaceuticals Ltd.
Prolong Pharmaceuticals, LLC
Richter Gedeon Nyrt.
Sandoz International GmbH